4.59000 USD
0.36
7.27%
Last update Dec 16, 3:59 PM EST
Market closed
Day range
4.57000
5.040000
Previous close
4.95000
Open
4.93000
Access this stock data via API
Subscribe
Arbutus Biopharma Corporation
4.59
0.36
7.27%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 529K 10.7M 1.8M 1.6M
Cost of revenue
Gross profit
Operating expense
Research & development 5.8M 5.5M 9.0M 8.8M
Selling general and admin 3.0M 3.3M 5.8M 4.7M
Other operating expenses
Operating income -8.3M 1.9M -13.0M -11.9M
Non operating interest income
Income 952K 1.0M 1.2M 1.5M
Expense 23K 28K 28K 30K
Other income expense -378K -404K -12.7M -2.0M
Pretax income -7.7M 2.5M -24.5M -12.5M
Tax provision
Net income -7.7M 2.5M -24.5M -12.5M
Basic EPS 0.0 0.0 -0.1
Diluted EPS 0.0 0.0 -0.1
Basic average shares 191.8M 191.6M 190.7M
Diluted average shares 191.8M 192.4M 190.7M
EBITDA -7.3M 3.0M -11.5M -10.2M
Net income from continuing op. -7.7M 2.5M -24.5M -12.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 30 minutes

03:29
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).